Preoperative serum CA 19-9 > 1000 u/ml: Another prognostic factor or a contraindication to surgery? Results of a case-match study

Aims: Evaluate disease free (DFS) ad overall survival (OS) of patients with pancreatic adenocarcinoma and preoperative level of CA19-9>1000 u/ml in comparison with similar treated patients.

Saved in:
Bibliographic Details
Published inPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] Vol. 15; no. 3; pp. S96 - S97
Main Authors Capretti, Giovanni Luigi, Gavazzi, Francesca, Uccelli, Fara, Fiore, Barbara, Tinti, Carlotta, Ridolfi, Cristina, Zerbi, Alessandro
Format Journal Article
LanguageEnglish
Published Philadelphia Elsevier B.V 01.06.2015
Elsevier Limited
Subjects
Chemotherapy
Endocrinology & Metabolism
Gastroenterology and Hepatology
Surgery
Online AccessGet full text

Cover

More Information
Summary:Aims: Evaluate disease free (DFS) ad overall survival (OS) of patients with pancreatic adenocarcinoma and preoperative level of CA19-9>1000 u/ml in comparison with similar treated patients.
ISSN:1424-3903
1424-3911
DOI:10.1016/j.pan.2015.05.351